| Mutation type:Point | Mutation effect:Missense | Nucleotide number:26 | |||
| Genome location:Exon2 | Subdomain:Signal peptide | ||||
| Alpha missense prediction value:0.2143 | Alpha missense prediction class:benign | ||||
| No. of patients reported: 4 | |||||
| Patient information: Monoallelic variation (4); Biallelic variation (0) | |||||
| Patient | Sex | Age | Genotype | PC: amidolytic act (%) | PC: clotting act (%) | PC: Ag (%) | PCD type | Clinical presentation (age) | First onset age | Country | Comments | Reference |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NA | 74 | hetero | NA | 53 | 50 | I | Other VTE | 74 | France | NA | PMID: 32717757 |
| 2 | F | 68 | hetero | 48 | NA | 36 | I | asymptomatic | 68 | China | NA | PMID: 25393254 |
| 3 | F | 42 | hetero | 55 | NA | 34 | I | asymptomatic | 42 | China | NA | PMID: 25393254 |
| 4 | NA | NA | hetero | NA | 36 | 40 | I | NA | NA | France | NA | PMID: 7482420 |
| Mutation type:Point; Point | Mutation effect:Missense; Missense | Nucleotide number:26; 1010 | |||
| Genome location:Exon2; Exon9 | Subdomain:Signal peptide; Serine protease | ||||
| Alpha missense prediction value:0.2143; 0.2048 | Alpha missense prediction class:benign; benign | ||||
| No. of patients reported: 1 | |||||
| Patient information: Monoallelic variation (0); Biallelic variation (1) | |||||
| Patient | Sex | Age | Genotype | PC: amidolytic act (%) | PC: clotting act (%) | PC: Ag (%) | PCD type | Clinical presentation (age) | First onset age | Country | Comments | Reference |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | M | 16 | c.hetero | 21 | NA | 20 | I | DVT (14, 15) | 14 | China | NA | PMID: 25393254 |
| Mutation type:Point; Point; Deletion | Mutation effect:Missense; Missense; Inframe | Nucleotide number:26; 752; 574 | |||
| Genome location:Exon2; Exon8; Exon7 | Subdomain:Signal peptide; Serine protease; Linker | ||||
| Alpha missense prediction value:0.2143; 0.6673 | Alpha missense prediction class:benign; pathogenic | ||||
| No. of patients reported: 1 | |||||
| Patient information: Monoallelic variation (0); Biallelic variation (1) | |||||
| Patient | Sex | Age | Genotype | PC: amidolytic act (%) | PC: clotting act (%) | PC: Ag (%) | PCD type | Clinical presentation (age) | First onset age | Country | Comments | Reference |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | M | 30 | c.hetero | 36 | NA | 57 | I | DVT (28, 30) | 28 | China | PSD | PMID: 22951146 |
| Mutation type:Point; Point | Mutation effect:Missense; Missense | Nucleotide number:26; 752 | |||
| Genome location:Exon2; Exon8 | Subdomain:Signal peptide; Serine protease | ||||
| Alpha missense prediction value:0.2143; 0.6673 | Alpha missense prediction class:benign; pathogenic | ||||
| No. of patients reported: 1 | |||||
| Patient information: Monoallelic variation (0); Biallelic variation (1) | |||||
| Patient | Sex | Age | Genotype | PC: amidolytic act (%) | PC: clotting act (%) | PC: Ag (%) | PCD type | Clinical presentation (age) | First onset age | Country | Comments | Reference |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | M | NA | c.hetero | NA | NA | NA | I | Other VTE | NA | China | MVT (Other VTE) | PMID: 22951146 |